Cite
HARVARD Citation
Ighani, A. et al. (2019). Long‐term 52‐week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series. British journal of dermatology. pp. 211-212. [Online].